beta
IMMU
Immunomedics, Inc.
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
| Actual EPS |
|---|
| Consensus EPS |
| Estimated EPS |
| Number of Estimates |
| EPS Surprise |
Stats
Summary
Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ.
Market Cap: 20.3 Billion
Primary Exchange: NASDAQ
Website: http://www.immunomedics.com
Shares Outstanding: 231 Million
Float: 231 Million
Dividend: (%)
Beta: 1.9106493817560444
Sector: Health Technology
Industry: Biotechnology
Ethical Flags
Longest drawdown: 907 trading days
From: 2013-10-02 To: 2017-05-10
Lowest Point:
| Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
|---|
| Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
|---|